Cargando…
Long-Term Outcome of Neoadjuvant Tyrosine Kinase Inhibitors Followed by Complete Surgery in Locally Advanced Dermatofibrosarcoma Protuberans
SIMPLE SUMMARY: Wide surgical excision is the standard treatment for dermatofibrosarcoma protuberans. Imatinib mesylate has been reported as an efficient neoadjuvant therapy to surgery in order to reduce tumor size and post-operative relapses for locally advanced or unresectable tumors. The aim of t...
Autores principales: | Beaziz, Jessica, Battistella, Maxime, Delyon, Julie, Farges, Cécile, Marco, Oren, Pages, Cécile, Le Maignan, Christine, Da Meda, Laetitia, Basset-Seguin, Nicole, Resche-Rigon, Matthieu, Walter Petrich, Anouk, Kérob, Delphine, Lebbé, Céleste, Baroudjian, Barouyr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124845/ https://www.ncbi.nlm.nih.gov/pubmed/34066400 http://dx.doi.org/10.3390/cancers13092224 |
Ejemplares similares
-
Sonidegib in the Treatment of Locally Advanced Basal Cell Carcinoma: A Retrospective Study
por: HERMS, Florian, et al.
Publicado: (2022) -
Yield of FDG PET/CT for Defining the Extent of Disease in Patients with Kaposi Sarcoma
por: Pesqué, Louise, et al.
Publicado: (2022) -
EGFR is involved in dermatofibrosarcoma protuberans progression to high grade sarcoma
por: Osio, Amélie, et al.
Publicado: (2018) -
Systemic Treatment Initiation in Classical and Endemic Kaposi’s Sarcoma: Risk Factors and Global Multi-State Modelling in a Monocentric Cohort Study
por: Benajiba, Lina, et al.
Publicado: (2021) -
18FDG PET Assessment of Therapeutic Response in Patients with Advanced or Metastatic Melanoma Treated with First-Line Immune Checkpoint Inhibitors
por: Rivas, Alexia, et al.
Publicado: (2022)